BPC-157 vs TB-500
BPC-157 and TB-500 are the two most popular recovery peptides in research. Both are studied for tissue repair, but they work through fundamentally different mechanisms. BPC-157 (Body Protection Compound-157) is a pentadecapeptide derived from human gastric juice, while TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in cell migration and wound healing.
Researchers frequently compare these two peptides — and sometimes stack them — because they target complementary repair pathways. This comparison breaks down the key differences to help inform your research decisions.
Similarities
- =Both are studied primarily for tissue repair and recovery applications
- =Both are synthetic peptides available from research vendors in lyophilized powder form
- =Both have been studied in animal models for tendon, ligament, and muscle repair
- =Neither is FDA-approved for human use — both are research compounds only
- =Both are commonly available in 5mg vials from most peptide vendors
- =Both show favorable safety profiles in published animal studies
Key Differences
| Aspect | BPC-157 | TB-500 |
|---|---|---|
| Origin | Derived from human gastric juice protein BPC | Synthetic fragment of Thymosin Beta-4 |
| Primary Mechanism | Upregulates growth factor receptors (VEGF, FGF), modulates nitric oxide | Promotes actin polymerization, cell migration, and angiogenesis |
| Research Focus | GI tract healing, tendon repair, neuroprotection, inflammation | Cardiac repair, dermal wound healing, hair growth, systemic tissue repair |
| Stability | Highly stable in gastric juice — survives oral administration in studies | Less stable, typically administered via injection in research protocols |
| Typical Research Dose | 200-500 mcg/day in rodent-equivalent protocols | 2-5 mg twice weekly in rodent-equivalent protocols |
| Cost | Generally $25-60 per 5mg vial | Generally $30-70 per 5mg vial |
| Study Volume | 100+ published studies since 1993 | Fewer dedicated studies; most research on parent Thymosin Beta-4 |
Which to Choose for Your Research
GI and gut healing research
BPC-157BPC-157 has the strongest published evidence for gastrointestinal repair, including studies on ulcers, inflammatory bowel conditions, and gut-brain axis effects.
Tendon and ligament repair studies
Both / StackBoth peptides show tendon repair properties through different mechanisms. BPC-157 upregulates growth factors at the injury site, while TB-500 promotes cell migration to the area. Researchers often study them in combination.
Cardiac tissue research
TB-500Thymosin Beta-4 (TB-500's parent compound) has specific research on cardiac repair and reducing fibrosis after myocardial infarction.
Neuroprotection studies
BPC-157BPC-157 has published research on dopaminergic system protection, nerve regeneration, and traumatic brain injury models.
Systemic inflammation research
BPC-157BPC-157's anti-inflammatory effects are more broadly documented, with studies showing modulation of multiple inflammatory pathways.
The Verdict
BPC-157 and TB-500 are complementary rather than competing peptides. BPC-157 has a deeper research base with 100+ published studies and shows particular strength in GI healing and neuroprotection research. TB-500 excels in cardiac and dermal wound healing contexts. For general recovery research, BPC-157 is the more well-characterized starting point. For researchers interested in maximizing tissue repair pathways, studying both peptides — sometimes in combination — is common practice in the research community.
From a sourcing perspective, both are widely available from verified vendors. BPC-157 tends to be slightly cheaper per vial, but TB-500 is typically dosed less frequently in research protocols, so per-study costs are comparable.
Frequently Asked Questions
Can BPC-157 and TB-500 be used together in research?
Yes, many researchers study BPC-157 and TB-500 in combination (often called a 'healing stack'). The rationale is that they work through complementary mechanisms — BPC-157 upregulates growth factors while TB-500 promotes cell migration. There is limited published data on the combination specifically, but both have independent safety data in animal models.
Which is cheaper, BPC-157 or TB-500?
BPC-157 is generally slightly cheaper per vial ($25-60 for 5mg vs $30-70 for TB-500). However, TB-500 is typically used at higher doses but less frequently, so total research costs are similar. Use our price comparison tables for current vendor pricing.
Is BPC-157 or TB-500 better for tendon research?
Both show promise in tendon repair studies. BPC-157 has more published tendon-specific research, including studies on Achilles tendon transection models. TB-500 promotes cell migration which is relevant to tendon healing. Many researchers study both.
Which has more published research?
BPC-157 has significantly more published research — over 100 studies since 1993, primarily from Dr. Predrag Sikiric's group at the University of Zagreb. TB-500 has fewer dedicated studies, though its parent compound Thymosin Beta-4 has a broader research base.
BPC-157
View full compound page with vendor pricing.
Compare 81 products →TB-500
View full compound page with vendor pricing.
Compare 30 products →More Comparisons
For research reference only. Not medical advice. Not for human consumption. All compounds discussed are research chemicals.